The FDA notified small pharmacies that they will no longer be allowed to manufacture or distribute injectable vitamin C—despite its remarkable power to heal conditions that conventional medicine can't touch, and despite its being used in burn units around the world, including in the US, and its adoption by the military for this purpose. Intravenous vitamin C, administered under the care of a qualified physician, is being studied as an antiviral, antibacterial, anticancer powerhouse. The FDA suggests it be taken through the full approval process with either a New Drug Application or as an Investigational New Drug, but these can cost billions of dollars, and with NIH refusing to fund any research on IV vitamin C, it's practically a death sentence for such a vital and life-giving substance.
By Dave Mihalovic
Vitamin C has a broad spectrum antioxidant function with the ability to protect cell structures and DNA from free radical damage. Vitamin C is remarkably safe even in enormously high doses. Compared to commonly used prescription drugs, side effects are virtually nonexistent. No matter how high the concentration, vitamin C does not harm healthy cells. Yet, through an array of enzymatic and metabolic reactions, vitamin C has an impressive ability to protect and treat and wide range of diseases, including cancer. When something is this effective at treating disease, the FDA will stop at nothing to prevent public access.
The benefits of long-term vitamin C consumption in excess of the U.S. government recommended daily allowance (RDA) are widely acknowledged and include reduced risks of cancer, cardiovascular disease and cataracts. Higher-than-RDA vitamin C intakes have been associated with increases in good HDL cholesterol, decreases in LDL cholesterol oxidation, decreased blood …